# Structural Insights into the Interaction of Bisphenol F (BPF) and Bisphenol S (BPS) with Estrogen Receptors for Endocrine Safety Assessment

**Authors:** Ishfaq Ahmad Sheikh, Irshad Ul Haq Bhat, Torki A. Zughaibi, Mohamed A. Ghorab, Mohd Rehan, Majid Farhan Almutairi, Mohd Amin Beg, Zainab Tariq, Abdel Rezak M. Kadry

PMC · DOI: 10.3390/toxics14030262 · Toxics · 2026-03-17

## TL;DR

This study investigates how BPF and BPS, alternatives to BPA, interact with estrogen receptors to assess their potential as endocrine disruptors.

## Contribution

The study provides structural insights into BPF and BPS interactions with estrogen receptors using computational docking methods.

## Key findings

- BPF and BPS bind to ERα and ERβ but do not fully replicate the native ligand environment.
- BPF and BPS showed lower binding energy compared to estradiol, suggesting reduced affinity.
- The findings highlight the need for further investigation into their endocrine effects and safety.

## Abstract

Endocrine-disrupting chemicals (EDCs) perturb hormonal homeostasis, dysregulating multiple biological pathways and subsequently resulting in adverse health outcomes, including impaired reproductive function. Bisphenols represent an important subclass of EDCs with widespread use in polycarbonate plastics, thermal paper formulations, epoxy resins, and various everyday consumer products. Bisphenol A (BPA) was the first bisphenol to be synthesized, with extensive industrial applications. However, the concerns over its potential health risks, most notably reproductive dysfunction, prompted the development and introduction of several structurally related BPA analogues. That said, studies on the potential hormonal effects of these BPA analogues remain limited. Therefore, strengthening the evidence base on their reproductive safety evaluation remains an essential priority for ensuring their safe application, and this study contributes to that broader objective. The study aimed to explore the potential endocrine-disrupting activity of two commonly used BPA analogues, bisphenol F (BPF) and bisphenol S (BPS), on reproductive hormone signalling, contributing to ongoing safety assessment efforts. The molecular interactions of these analogues with the estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) were analyzed through structural binding characterization employing the induced fit docking (IFD) approach using the Schrödinger 2019 suite. The overall results revealed that the two indicated BPA analogues were placed successfully in the ligand-binding pockets of ERα and ERβ. Their binding pattern and molecular interactions showed certain similarities; however, they did not fully replicate the amino acid residue environment of the native ligands of ERα and ERβ, estradiol. Notably, the binding energy estimations revealed that BPF and BPS showed substantially lower values than those calculated for native ligands of ERα and ERβ. In summary, this study suggests that BPF and BPS exhibit lower predicted binding affinity toward ERα and ERβ under the applied molecular docking conditions. However, these computational findings do not establish receptor activation, endocrine potency, or safety outcomes, and the potential involvement of other reproductive signalling pathways warrants further investigation.

## Linked entities

- **Chemicals:** Bisphenol F (PubChem CID 12111), Bisphenol S (PubChem CID 6626), Bisphenol A (PubChem CID 6623), estradiol (PubChem CID 450)

## Full-text entities

- **Genes:** ESR2 (estrogen receptor 2) [NCBI Gene 2100] {aka ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2}, TRA (T cell receptor alpha locus) [NCBI Gene 6955] {aka IMD7, TCRA, TRA@}, esr1 (estrogen receptor 1) [NCBI Gene 259252] {aka ER[a], ESR, NR3A1, abrrl, eralpha, zfER[a]}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** injury to (MESH:D014947), dysregulation (MESH:D021081), infertility (MESH:D007246), endocrine disruption (MESH:D004700), hepatocellular carcinoma (MESH:D006528), BPF (OMIM:102510), impaired reproductive function (MESH:D060737), BPS (MESH:D018455)
- **Chemicals:** acid (MESH:D000143), Thr (MESH:D013912), Phe (MESH:D010649), IFD (-), Ala (MESH:D000409), hydrogen (MESH:D006859), BPA (MESH:C006780), BPF (MESH:C000611646), Leu (MESH:D007930), amino acid (MESH:D000596), Glu (MESH:D018698), Estradiol (MESH:D004958), epoxy (MESH:D004853), Ile (MESH:D007532), phthalate (MESH:C032279), water (MESH:D014867), Gly (MESH:D005998), BPS (MESH:C543008)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13030149/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13030149/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC13030149/full.md

---
Source: https://tomesphere.com/paper/PMC13030149